Multiple Sclerosis News Today Forums Forums Trials and Research Lower SPMS Risk Linked to Certain Initial Treatments, Study Reports

  • Lower SPMS Risk Linked to Certain Initial Treatments, Study Reports

    Posted by ms-news-today-moderator on February 7, 2019 at 11:44 am

    Initial treatment of RRMS with Gilenya, Tysabri or Lemtrada is associated with a lower risk of conversion to SPMS compared with interferon beta or Copaxone. Click here to learn more.

    What are your thoughts on this research?

    replied 5 years, 1 month ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.